POST-SURGICAL

Clinical trials for POST-SURGICAL explained in plain language.

Never miss a new study

Get alerted when new POST-SURGICAL trials appear

Sign up with your email to follow new studies for POST-SURGICAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope to stop lung Cancer's return after surgery

Disease control Recruiting now

This study is testing whether adding a new drug called zipalertinib to standard chemotherapy after lung cancer surgery works better than chemotherapy alone. It's for people with early-stage lung cancer who have specific, less common genetic changes in their tumor. The goal is to …

Matched conditions: POST-SURGICAL

Phase: PHASE3 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

POST-SURGICAL

Get alerted when new POST-SURGICAL trials appear

New hope to stop lung Cancer's return after surgery